Pharmadrug Inc
Change company Symbol lookup
Select an option...
LMLLF Pharmadrug Inc
WFC-Y Wells Fargo & Co
FORR Forrester Research Inc
CBTTF Cathedra Bitcoin Inc
IPVF InterPrivate III Financial Partners Inc
AAPL Apple Inc
MFD Macquarie/First Trust Global Infrastructure/Utilities Dividend & Income
SLNG Stabilis Solutions Inc
THO Thor Industries Inc
TME Tencent Music Entertainment Group
Go


Based in Canada
Company profile

Pharmadrug Inc. is a Canada-based specialty pharmaceutical company, which is focused on the research, development and commercialization of controlled substances and medicines such as psychedelics, cannabis and naturally derived approved drugs. The Company operates through three divisions: Pharmadrug Production GmbH (Pharmadrug Production), Interrobang Ltd. (Interrobang), and Sairiyo Therapeutics Inc. (Sairiyo). Pharmadrug Production is a German medical cannabis distribution company, which imports and distributes Bedrocan cannabis from the Netherlands. Interrobang are licensed retailers in the Netherlands that are legally allowed to sell psilocybin bearing truffles. Interrobang is building a vertically integrated retail business with the goal to elevate the use of functional mushrooms, and psilocybin mushrooms. Sairiyo is a biotechnology company focused on repurposing and developing improved formulations of naturally derived compounds for serious, rare, and life-threatening diseases.

Closing Price
$0.0274
Day's Change
-0.0009 (-3.31%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0288
Day's Low
0.0274
Volume
(Light)
Volume:
65,211

10-day average volume:
97,982
65,211

Display:

Providers:

UpdateCancel
6 providers
May 23, 2022
BioMed Stocks On the Move: GeoVax Labs, Nova Mentis, SIGA and PharmaDrug; Life Sciences Leaders Report Latest Advances in Antiviral Vaccines, and Novel Therapeutics for Oncology, Glaucoma and Autism

EQNX::TICKER_START (NasdaqGM:SIGA),(Other OTC:NMLSF),(CNSX:NOVA.CN),(NASDAQ:GOVX),(Other OTC:LMLLF),(CNSX:PHRX.CN), EQNX::TICKER_END Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments...(Globe Newswire)

May 17, 2022
Healthcare Breakthroughs: IDRA, NMLSF, LMLLF, BBI; Life Sciences Leaders Report Latest Advances in Novel Therapeutics for Autism, Oncology, Autoimmune Diseases, and Glaucoma

EQNX::TICKER_START (Other OTC:NMLSF),(CNSX:NOVA.CN),(NASDAQ:BBI),(NASDAQ:IDRA),(Other OTC:LMLLF),(CNSX:PHRX.CN), EQNX::TICKER_END Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and...(Globe Newswire)

May 13, 2022
BioMed Stocks On the Move: Nova Mentis, PolarityTE, Veru, and PharmaDrug; Life Sciences Leaders Report Latest Advances in Regenerative Tissue Technology, Novel Therapeutics for Oncology, COVID, Glaucoma, and Autism

EQNX::TICKER_START (CNSX:NOVA.CN),(Other OTC:NMLSF),(NASDAQ:PTE),(NASDAQ:VERU),(Other OTC:LMLLF),(CNSX:PHRX.CN), EQNX::TICKER_END Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and...(Globe Newswire)

May 04, 2022
BioMed Momentum: NMLSF, BBI, LMLLF, VERU; Life Sciences Leaders Report Latest Advances in New Drug Development for Autism, COVID-19, Oncology, and Glaucoma

EQNX::TICKER_START (Other OTC:NMLSF),(CNSX:NOVA.CN),(NASDAQ:VERU),(Other OTC:LMLLF),(CNSX:PHRX.CN),(NASDAQ:BBI), EQNX::TICKER_END Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and...(Globe Newswire)

May 03, 2022
Pharmadrug Advances Opthalmology Program with Final Selection of Lead DMT-Analogue to Provide Sustained Control of Elevated Intraocular Pressure for Glaucoma

Toronto, Ontario--(Newsfile Corp. - May 3, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and...(Newsfile)

April 26, 2022
BioMed Momentum: AGRX, NMLSF, LMLLF, VERU; Life Sciences Leaders Report Latest Advances in New Drug Development for COVID-19, Oncology, Glaucoma, and Autism

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO's of: Veru Inc. (NASDAQ: VERU), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Agile Therapeutics (NASDAQ...(Globe Newswire)

April 25, 2022
Next Super Stocks on the Move: NEXCF, NMLSF, OGGFF, LMLLF; Driving Disruptive Innovation with Explosive Revenue Growth Potential in Biopharma, E-Commerce, Metaverse, and Plant-Based Brands

Wall Street Reporter, the trusted name in financial news since 1843, is highlighting the latest CEO comments and news from companies recently presenting at its highly acclaimed NEXT SUPER STOCK investor conferences, and online events which engage...(Globe Newswire)

April 19, 2022
Healthcare Breakthroughs: AGRX, NMLSF, BBI, LMLLF; BioMed Leaders Report Latest Advances in New Drug Development for Women's Health, Autism, Glaucoma, and Cancer Therapeutics

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO's of: Brickell Biotech (NASDAQ: BBI), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Agile Therapeutics...(Globe Newswire)

PharmaDrug Advances Oncology Program with Filing of Provisional Patent Following Positive Findings for the Combination of PD-001 and Frontline Chemotherapy in Prostate Cancer Study

Toronto, Ontario--(Newsfile Corp. - April 19, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances...(Newsfile)

April 14, 2022
BioMed Momentum: VERU, NMLSF, PHRX, CRXT; Life Sciences Leaders Report Latest Advances in New Drug Development for COVID-19, Cancers, Glaucoma, and Autism

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Veru Inc. (NASDAQ: VERU), Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Clarus Therapeutics (NASDAQ...(Globe Newswire)

April 12, 2022
BioMed Stocks On the Move: Nova Mentis, PolarityTE, Biodesix and PharmaDrug; Life Sciences Leaders Report Latest Advances in Regenerative Tissue Technology, New Drugs for Cancers, Glaucoma, and Autism, and Diagnostics.

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO's of: PolarityTE, Inc. (NASDAQ: PTE) Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Biodesix, Inc. (NASDAQ...(Globe Newswire)

April 11, 2022
Healthcare Breakthroughs: Veru, Nova Mentis, Phio, and PharmaDrug; Visionary CEOs Report Latest Advances in New Drug Development for COVID-19, Cancers, Glaucoma, and Autism

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO's of: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA), Phio Pharmaceuticals (NASDAQ: PHIO), Veru Inc...(Globe Newswire)

April 08, 2022
BioMed Leaders: Sunshine Biopharma, PharmaDrug, Blue Water Vaccines, and MedAvail; Visionary CEOs Advancing Healthcare, with Vaccines, Cancer Therapeutics, and Affordable Pharmaceuticals

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: Sunshine Biopharma, Inc. (NASDAQ: SBFM), PharmaDrug (OTC: LMLLF) (CSE: PHRX), Blue Water Vaccines (NASDAQ...(Globe Newswire)

April 07, 2022
PharmaDrug Advances DMT-Analogue Program for Glaucoma with Production of Medical Device Designed to Provide Sustained Control of Elevated Intraocular Pressure

Toronto, Ontario--(Newsfile Corp. - April 7, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances...(Newsfile)

April 04, 2022
Leaders: ChargePoint, PharmaDrug, DeepMarkit, and DraftKings; Visionary CEOs Highlight New Trends in Electric Vehicles, Biotech, Carbon Credits, NFTs and Sports Betting

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: ChargePoint Holdings, Inc. (NYSE: CHPT), PharmaDrug (OTC: LMLLF) (CSE: PHRX) DeepMarkit (OTC: MKTDF)...(Globe Newswire)

April 01, 2022
Pharmadrug Advances PD-001, Its Patented, Improved Version of Cepharanthine for Oncology and Infectious Disease

Toronto, Ontario--(Newsfile Corp. - April 1, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances...(Newsfile)

March 31, 2022
Megatrends: CEOs of NIO, PharmaDrug, SoFi, and NuRAN Advancing New Growth Opportunities in Electric Vehicles, Biotech, Mobile, and Fintech

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEOs of: NIO, Inc. (NYSE:NIO), PharmaDrug (OTC: LMLLF) (CSE: PHRX), NuRAN Wireless (OTC: NRRWF) (CSE: NUR) and SoFi...(Globe Newswire)

Leaders: Moderna, Tilray, PharmaDrug, and Vinco; Visionary CEO Highlight New Trends in Vaccines, Biotech, Digital Media, and Consumer Brands

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO's of: Moderna, Inc. (NASDAQ: MRNA), PharmaDrug (OTC: LMLLF) (CSE: PHRX) Tilray, Inc. (NASDAQ:TLRY) and Vinco...(Globe Newswire)

March 09, 2022
PharmaDrug Announces Interim Positive Findings for the Combination of Cepharanthine and Frontline Chemotherapy for IND-Enabling Prostate Cancer Study

Toronto, Ontario--(Newsfile Corp. - March 9, 2022) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances...(Newsfile)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.